This suggests a dichotomous role for IL4I1 in solid tumors compared to B-cell lymphomas, which may be related to the physiological regulatory role of IL4I1 in B-cell activation (376), but requires further substantiating evidence. The gene discussed is IL4I1; the disease is B-cell non-Hodgkin lymphoma.